Company records / eurekatherapeutics.com

Eureka Therapeutics

Eureka Therapeutics (eurekatherapeutics.com): no confident changes recorded yet; website history since August 2017. Homepage last checked 6 November 2026.

First recorded website

Observed 25 August 2017

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Eureka Therapeutics | Therapeutics

Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pi

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

August 2018 – November 2026 · 13 captures · latest observed messagingHARNESSING THE EVOLUTIONARY POWER OF
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T c
This wording observed 6 November 2026.
current websiteHistorical capture not publicly available
Inspect 13 captures in this group
- 19 August 2018 · Harnessing the evolutionary power of the immune system with the goal of curing cancer archived page
- 19 July 2019 · Harnessing the evolutionary power of the immune system with the goal of curing cancer archived page
- 28 February 2021 · Harnessing the evolutionary power of the immune system with the goal of curing cancer archived page
- 16 February 2022 · Harnessing the evolutionary power of the immune system with the goal of curing cancer archived page
- 5 July 2022 · HARNESSING THE EVOLUTIONARY POWER OF archived page
- 19 August 2023 · HARNESSING THE EVOLUTIONARY POWER OF archived page
- 12 July 2024 · HARNESSING THE EVOLUTIONARY POWER OF archived page
- 29 April 2025 · HARNESSING THE EVOLUTIONARY POWER OF archived page
- 10 April 2026 · HARNESSING THE EVOLUTIONARY POWER OF archived page
- 10 April 2026 · HARNESSING THE EVOLUTIONARY POWER OF archived page
- 30 May 2026 · HARNESSING THE EVOLUTIONARY POWER OF archived page
- 5 November 2026 · HARNESSING THE EVOLUTIONARY POWER OF current websiteHistorical capture not publicly available
- 6 November 2026 · HARNESSING THE EVOLUTIONARY POWER OF current websiteHistorical capture not publicly available
Seen August 2017 · 1 captureEureka Therapeutics | Therapeutics
Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pi
This wording observed 25 August 2017.
archived page

Cite this record

StartupHistory, “Eureka Therapeutics” company record, https://startuphistory.org/c/eurekatherapeutics.com

Machine-readable: /c/eurekatherapeutics.com.json. How changes are found: method.